在生殖失败时使用塔克罗利斯治疗
Koji Nakagawa1, Yuji Orita2, Keiji Kuroda3
1Center for Reproductive Medicine and Implantation Research, Sugiyama Clinic Shinjuku, Japan.
Journal of reproductive immunology
|December 24, 2025
概括
使用塔克罗利斯的免疫疗法显示出在体外受精 (IVF) 后治疗重复植入失败 (RIF) 的前景. 大约三分之一的RIF病例可能涉及免疫成分,这表明塔克罗利斯可以提高怀孕成功率.
科学领域:
- 生殖免疫学 生殖免疫学
- 在体外受精 (IVF)
- 免疫治疗是一种免疫疗法.
背景情况:
- 重复植入失败 (RIF) 影响了试管婴儿的成功,其中很大一部分可能与免疫因素有关.
- 塔克罗利斯是一种氨酸抑制剂,已在RIF中作为免疫疗法进行了大约十年的研究.
- 之前的研究报告了临床怀孕率约64%与tacrolimus治疗RIF.
研究的目的:
- 在RIF患者中重新评估tacrolimus免疫疗法的疗效.
- 评估RIF病例中免疫媒介排斥标记的流行程度.
- 为了探索潜在的扩大用于产科并发症中tacrolimus的指示.
主要方法:
- 在接受TACROLIMUS治疗的RIF患者中,对临床妊娠率的回顾性分析.
- 评估Th1/Th2细胞比率以确定免疫媒介排斥.
- 对RIF和相关产科疾病中塔克罗利斯的现有文献的审查.
主要成果:
- 一个最近的队列证明了临床怀孕率为57.1%与tacrolimus治疗RIF.
- 大约35.9%的RIF病例表现出Th1/Th2细胞比率,表明免疫媒介排斥.
- 塔克罗利木斯还显示出在治疗复发性流产 (RPL) 和预防产科并发症方面的潜力.
结论:
- 塔克罗利斯免疫疗法仍然是RIF的可行选择,实现高怀孕率.
- 显著比例的RIF病例具有免疫基础,支持免疫调节治疗.
- 需要进一步的确认性试验来确定塔克罗利斯在RIF和其他产科疾病中的作用.
相关概念视频
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
454
Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...
454
Infertility in Females
3.6K
Female infertility is defined as the inability to conceive after a year of regular, unprotected intercourse and affects about 10–15% of couples worldwide. The primary cause of female infertility is ovulatory disorders, which hinder the release of eggs. These disorders can be classified as hypothalamic amenorrhea, polycystic ovarian syndrome (PCOS), premature ovarian failure, and hyperprolactinemic anovulation disorders.
Endometriosis, a condition characterized by abnormal growth of...
Endometriosis, a condition characterized by abnormal growth of...
3.6K
Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids
405
Glucocorticoids, a class of anti-inflammatory drugs, are pivotal in treating moderate to severe Crohn's disease by inducing remission. They exhibit their anti-inflammatory action by inhibiting the production of inflammatory cytokines such as tumor necrosis factor (TNF)-α, interleukin (IL)-1, and chemokines like IL-8. In addition, they reduce the expression of inflammatory cell adhesion molecules and inhibit gene transcription of nitric oxide synthase, phospholipase A2, cyclooxygenase-2...
405


